Johnson & Johnson é uma holding company engaged na research, development, manufacture, e sale of healthcare produtos em todo o mundo. It opera por meio de two primary segments: inovadores Medicine, focando em pharmaceuticals in oncology, immunology, neuroscience, e other therapeutic areas, e MedTech, encompassing medical devices in cardiovascular, orthopaedics, vision care, e electrophysiology. Key produtos include DARZALEX for oncology, TREMFYA for immunology, e inovadores platforms like OMNYPULSE for pulsed-field ablation treatments. Fundada em 1887 e Com sede em New Brunswick, New Jersey, a empresa emprega aproximadamente 139,800 funcionários e generates substancial revenue, reaching $94.2 billion na latest full year with operational growth of 5.3%, driven by a robust pipeline e R&D investments exceeding $32 billion. Johnson & Johnson mantém strong financials, incluindo a dividend yield around 2.1% e consistent payout growth, positioning it as a Dividend King na healthcare sector. Its diversified portfolio ensures stable cash flows, apoiaring global distribution por meio de hospitals, physicians, clinics, e partners, while addressing major health challenges em consumer, business, e institutional markets.